Aimei Health Technology Co Ltd (AFJK) has a current Price-to-Book (P/B) ratio of -135.02. Compared to its 3-year average P/B ratio of -206.15, the current P/B ratio is approximately -34.51% higher. Relative to its 5-year average P/B ratio of -206.15, the current P/B ratio is about -34.51% higher. Aimei Health Technology Co Ltd (AFJK) has a Forward Free Cash Flow (FCF) yield of approximately -0.15%. Compared to its 3-year average FCF yield of -0.52%, the current FCF yield is approximately -70.04% lower. Relative to its 5-year average FCF yield of -0.52%, the current FCF yield is about -70.04% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AFJK competitors is 0.00, providing a benchmark for relative valuation. Aimei Health Technology Co Ltd Corp (AFJK.O) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AFJK increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AFJK in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AFJK currently overvalued or undervalued?

What is Aimei Health Technology Co Ltd (AFJK) fair value?

AFJK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Aimei Health Technology Co Ltd (AFJK) is between to according to relative valuation method.

How does AFJK's valuation metrics compare to the industry average?

The average P/S ratio for AFJK's competitors is 0.00, providing a benchmark for relative valuation. Aimei Health Technology Co Ltd Corp (AFJK) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Aimei Health Technology Co Ltd (AFJK) as of Mar 03 2026?

As of Mar 03 2026, Aimei Health Technology Co Ltd (AFJK) has a P/B ratio of -135.02. This indicates that the market values AFJK at -135.02 times its book value.

What is the current FCF Yield for Aimei Health Technology Co Ltd (AFJK) as of Mar 03 2026?

As of Mar 03 2026, Aimei Health Technology Co Ltd (AFJK) has a FCF Yield of -0.15%. This means that for every dollar of Aimei Health Technology Co Ltd's market capitalization, the company generates -0.15 cents in free cash flow.

What is the current Forward P/E ratio for Aimei Health Technology Co Ltd (AFJK) as of Mar 03 2026?

As of Mar 03 2026, Aimei Health Technology Co Ltd (AFJK) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Aimei Health Technology Co Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Aimei Health Technology Co Ltd (AFJK) as of Mar 03 2026?

As of Mar 03 2026, Aimei Health Technology Co Ltd (AFJK) has a Forward P/S ratio of 0.00. This means the market is valuing AFJK at $0.00 for every dollar of expected revenue over the next 12 months.

AFJK Valuation